Literature DB >> 16797165

Antimicrobial activities of human beta-defensins against Bacillus species.

Preeti Yadava1, Chun Zhang, Jing Sun, Jeffrey A Hughes.   

Abstract

Natural defences in the human body function to protect us from numerous environmental toxins and exposure to potential harmful biological agents. An important frontline defence is antimicrobial peptides. These peptides occur at environmental interfaces and serve to limit bacterial invasion. There has been little work comparing specific peptides as potential antimicrobial compounds. In this study, we evaluated the antimicrobial activity of peptides from the human beta-defensin (HBD) family against four species of Bacillus, chosen as models for Bacillus anthracis, a potential bioweapon. The impact of peptide concentration, sequence and protein binding was evaluated on their biological activity. The results indicated that HBD-3 was the most biologically active against Bacillus subtilis and Bacillus licheniformis, whilst HBD-2 was found to be most active against Bacillus cereus and Bacillus thuringiensis. Moreover, the antimicrobial activity of the peptides was directly related to peptide concentration and indirectly related to albumin concentration (i.e. protein binding).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16797165     DOI: 10.1016/j.ijantimicag.2006.02.021

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  7 in total

1.  Toward full-sequence de novo protein design with flexible templates for human beta-defensin-2.

Authors:  Ho Ki Fung; Christodoulos A Floudas; Martin S Taylor; Li Zhang; Dimitrios Morikis
Journal:  Biophys J       Date:  2007-09-07       Impact factor: 4.033

2.  Bacterial colonization and beta defensins in the female genital tract in HIV infection.

Authors:  Wei Jiang; Santosh K Ghosh; Rebecca Flyckt; Magdalena Kalinowska; David Starks; Richard Jurevic; Aaron Weinberg; Michael M Lederman; Benigno Rodriguez
Journal:  Curr HIV Res       Date:  2012-09       Impact factor: 1.581

3.  Fusobacterium nucleatum-associated beta-defensin inducer (FAD-I): identification, isolation, and functional evaluation.

Authors:  Sanhita Gupta; Santosh K Ghosh; Mary E Scott; Brian Bainbridge; Bin Jiang; Richard J Lamont; Thomas S McCormick; Aaron Weinberg
Journal:  J Biol Chem       Date:  2010-09-16       Impact factor: 5.157

4.  Novel synthetic, salt-resistant analogs of human beta-defensins 1 and 3 endowed with enhanced antimicrobial activity.

Authors:  Olga Scudiero; Stefania Galdiero; Marco Cantisani; Rosa Di Noto; Mariateresa Vitiello; Massimiliano Galdiero; Gino Naclerio; Jean-Jacques Cassiman; Carlo Pedone; Giuseppe Castaldo; Francesco Salvatore
Journal:  Antimicrob Agents Chemother       Date:  2010-03-22       Impact factor: 5.191

Review 5.  Microbial symbiosis with the innate immune defense system of the skin.

Authors:  Richard L Gallo; Teruaki Nakatsuji
Journal:  J Invest Dermatol       Date:  2011-06-23       Impact factor: 8.551

Review 6.  Antimicrobial peptides: old molecules with new ideas.

Authors:  Teruaki Nakatsuji; Richard L Gallo
Journal:  J Invest Dermatol       Date:  2011-12-08       Impact factor: 8.551

7.  The capsule of Bacillus anthracis protects it from the bactericidal activity of human defensins and other cationic antimicrobial peptides.

Authors:  David K O'Brien; Wilson J Ribot; Donald J Chabot; Angelo Scorpio; Steven A Tobery; Tanya M Jelacic; Zhibin Wu; Arthur M Friedlander
Journal:  PLoS Pathog       Date:  2022-09-29       Impact factor: 7.464

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.